Inhibitors of HCV NS5A

摘要

The present invention provides compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

主权项

1. A compound of Formulae I-III wherein: each A is independently selected from the group consisting of each R1 and R2 are independently selected from the group consisting of H, lower alkyl, or aryl; each R3 is independently selected from the group consisting of H, lower alkyl, or C(═O)OR4;
R4 is lower alkyl; each X is independently selected from the group consisting of H and Cl; and each Y1 and Y2 are independently selected from the group consisting of H or F; or a pharmaceutically acceptable salt thereof.